The Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For Supremacy? [qM3cq-fQVYC]

The Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For Supremacy? [qM3cq-fQVYC]

| 1h 28m 28s | Video has closed captioning.

The market for weight-loss drugs is expanding in a big way. Industry experts now say annual sales could hit $150 billion in just a few years, making losing weight one of the world's largest pharmaceutical markets. This is mostly due to big players like Novo Nordisk and Eli Lilly, makers of drugs such as Ozempic and Mounjaro. Lately, however, new competition has come to the table, and they're working on therapies to improve weight loss and mitigate gastrointestinal side effects. So, which weight-loss drug will come out as the ultimate heavyweight champion? New to trading? Check out our daily newsletter! Get more IBD by subscribing to our channel: Visit our website: Like us on Facebook: Follow us on Twitter: Follow us on Instagram: Follow us on StockTwits: Follow us on LinkedIn: Follow us on TikTok: Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market. #InvestorsBusinessDaily #IBD #lumalite diet pills #destiny gummies kelly clarkson #best fast weight loss pills